Pearle Vision announces 2013 expansion

Article

Ernie Bowling, OD, reports on retail outlet Pearle Vision’s plans for expansion this year, during the 90th annual SECO International meeting in Atlanta.

Chief Optometric Editor Ernie Bowling, OD, reports on retail outlet Pearle Vision’s plans for expansion this year, during the 90th annual SECO International meeting in Atlanta:

Pearle Vision, North America’s largest licensed optical brand, outlined its 2013 expansion plans. Tammy Reaves, vice president of licensing and development for Pearle Vision, said the company intends to convert 35 corporate locations to franchise opportunities in addition to building up to 10 new stores this year.

The company has identified Florida, Ohio, and Michigan as the first markets for its re-licensing efforts. Specifically in Florida, Pearle is looking to convert corporate locations in Miami, West Palm Beach, Naples, Jacksonville, and Orlando to licensed locations. In Ohio, the company intends to convert locations in Cleveland, Columbus, and Cincinnati. Michigan centers in Detroit, Grand Rapids, Lansing, and Flint are available.

“We are looking for doctors who desire to work with a proven brand and provide superior eyecare and patient service,” Reaves said.

Pearle Vision is built around a doctor-centered business model and is owned by eyewear manufacturer and distributor Luxottica.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.